<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>43</volume><submitter>Glaser A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The association between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) remains controversial, largely due to a detection bias in traditional observational studies.&lt;h4>Objective&lt;/h4>To assess the association between BPH and PCa using inherited single nucleotide polymorphisms (SNPs).&lt;h4>Design setting and participants&lt;/h4>The participants were White men from the population-based UK Biobank (UKB).&lt;h4>Outcome measurements and statistical analysis&lt;/h4>The association between BPH and PCa was tested for (1) phenotypic correlation using chi-square, (2) genetic correlation (&lt;i>r&lt;/i> &lt;sub>g&lt;/sub>) based on genome-wide SNPs using linkage disequilibrium score regression, and (3) cross-disease genetic associations based on known risk-associated SNPs (15 for BPH and 239 </pubmed_abstract><journal>European urology open science</journal><pagination>54-61</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9638770</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.</pubmed_title><pmcid>PMC9638770</pmcid><pubmed_authors>Vickman RE</pubmed_authors><pubmed_authors>Franco OE</pubmed_authors><pubmed_authors>Isaacs WB</pubmed_authors><pubmed_authors>Lanman NA</pubmed_authors><pubmed_authors>Shi Z</pubmed_authors><pubmed_authors>Hayward SW</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Crawford SE</pubmed_authors><pubmed_authors>Helfand BT</pubmed_authors><pubmed_authors>Glaser A</pubmed_authors><pubmed_authors>Wei J</pubmed_authors><pubmed_authors>Lilly Zheng S</pubmed_authors><pubmed_authors>Ladson-Gary S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer.</name><description>&lt;h4>Background&lt;/h4>The association between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) remains controversial, largely due to a detection bias in traditional observational studies.&lt;h4>Objective&lt;/h4>To assess the association between BPH and PCa using inherited single nucleotide polymorphisms (SNPs).&lt;h4>Design setting and participants&lt;/h4>The participants were White men from the population-based UK Biobank (UKB).&lt;h4>Outcome measurements and statistical analysis&lt;/h4>The association between BPH and PCa was tested for (1) phenotypic correlation using chi-square, (2) genetic correlation (&lt;i>r&lt;/i> &lt;sub>g&lt;/sub>) based on genome-wide SNPs using linkage disequilibrium score regression, and (3) cross-disease genetic associations based on known risk-associated SNPs (15 for BPH and 239 </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-19T23:14:23.118Z</modification><creation>2025-04-19T23:14:23.118Z</creation></dates><accession>S-EPMC9638770</accession><cross_references><pubmed>36353071</pubmed><doi>10.1016/j.euros.2022.07.004</doi></cross_references></HashMap>